Ortho implant firm Amedica targets $35m public offering
This article was originally published in Clinica
Executive Summary
Another week and another medtech firm files for an initial public offering. This time it is Salt Lake City, Utah-based Amedica, which develops silicon nitride-based implants for spinal use and joint replacement, which is hoping to raise $35m. The firm says the material offers an alternative to polyether-etherketone (PEEK) and titanium that is “osteopromotive, anti-infective and may result in faster fusion.”